ReviewDrug metabolism and disposition: the biological fate of chemicals2024

Kinase Inhibitors FDA Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities.

Bethany D Latham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.